ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Health Care

Omron launches remote medical system in US for hypertension

App will follow as company looks to market telemed systems overseas

Omron aims to gain 100,000 users in five years. 

KYOTO -- Omron will enter the remote medicine business in the U.S. for patients with hypertension, or high blood pressure, in partnership with hospitals in August.

The Japanese company will first launch the business, called VitalSight, in the U.S., where online medical practice is more accepted than in Japan. Omron will send blood pressure manometers and communication equipment to patients, whose data will be automatically added to a hospital's digital medical records.

As the novel coronavirus spreads, many hospitals have accelerated the introduction of telemedicine and other technology that can increase efficiency and safety, as some virus patients do not have to go to hospitals for treatment.

Omron will soon offer VitalSight to Mount Sinai Hospital in New York. Doctors can decide how to treat patients based on data input into the system. The company will also launch an associated smartphone app within the year, and hopes to have 100,000 users in five years.

Since 2019, public medical insurance in the U.S. covers blood pressure management by remote for people 65 years or older. Insurance will pay hospitals $65 per month for each VitaSight patient, a portion of which goes to Omron.

The Japanese public health care system does not cover telemedicine, pushing companies like Omron into overseas markets that have less strict regulations.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more